The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data.

Source:http://linkedlifedata.com/resource/pubmed/id/18174220

Download in:

View as

General Info

PMID
18174220